Life Magnetics, Inc.

An at-home medical testing platform funded by the National Science Foundation
Detroit, 
MI
Investment type:
Equity
(Priced Round)
Target raise:
$200,022
 - $1,000,008
Minimum investment:​
$100
End date:
Aug 06, 2021
Share
Share on facebook
Share on twitter
Share on linkedin
Share on email
Highlights

  • RNA is the future of medicine. The mRNA COVID-19 vaccines are just the beginning
  • RNA sequencing will revolutionize diagnostic testing giving data sets 20x larger than DNA sequencing
  • Our transport solution is a quantum mechanical mechanism that’s novel and vetted by top scientist
  • Manufacturing capacity for $2M a year in sales built out and ready to go
Our Story

Life Magnetics, Inc. provides RNA shipping and storage solutions. Remember how we couldn't do COVID-19 at-home testing? and all the mRNA vaccines had to be cold stored? Some at -94 C? Even COVID-19 itself can't survive 30 seconds of sunlight. RNA is not a stable molecule. It's hard to transport. We're addressing those issues.
Our Ambition

By some estimates, by 2040 80% of drugs will be mRNA drugs. The first mRNA drug was released in 2018 but when COVID hit, almost all the vaccines were mRNA vaccines. We've known for some time that RNA drugs are the next evolution of pharmaceuticals but it's hard to ship and store these drugs. In diagnostics, RNA sequencing provides the largest datasets, but those datasets are skewed if the RNA is degrading in transport. We have solved those logistics issues. These projections are not guaranteed.